Characteristics of recipients of free prescription drug samples: A nationally representative analysis

American Journal of Public Health

Volumn 98, Issue 2, 2008, Pages 284-289

  Cutrona, Sarah L ^a,b,c   Woolhandler, Steffie ^a,b   Lasser, Karen E ^a,b   Bor, David H ^a,b   McCormick, Danny ^a,b   Himmelstein, David U ^a,b  

^a Cambridge Health Alliance ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CAMBRIDGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CELECOXIB; FEXOFENADINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; ROFECOXIB;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG SAFETY; ETHNICITY; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; INFANT; MALE; PRESCRIPTION; SOCIOECONOMICS; AGED; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; INCOME; INFORMATION PROCESSING; INSURANCE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DRUG INDUSTRY; FEMALE; HUMANS; INCOME; INFANT; INFANT, NEWBORN; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MARKETING OF HEALTH SERVICES; MIDDLE AGED; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 39649114115     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.114249     Document Type: Article

References (29)

1. Donohue JM, Cevaso M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-681.
2. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498-505.
3. Ma J, Stafford RS, Cockburn IM, Finkelstein SN. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin Ther. 2003;25:1503-1517.
4. Charatan F. Hospital bans free drug samples. West J Med. 2001;174:236-237.
5. Dill JL, Generali JA. Medication sample labeling practices. Am J Health Syst Pharm. 2000;57:2087-2090.
6. Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. 2000;49:811-816.
7. Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. J Fam Pract. 1992;34:42-48.
8. Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278:141-143.
9. Tong KL, Lien CY. Do pharmaceutical representatives misuse their drug samples? Can Fam Physician. 1995;41:1363-1366.
10. Peterson MC, Ebbert TL, Edwards MW, Willmore J. Disposition of pharmaceutical samples from a private medical clinic. J Am Pharm Assoc. 2004;44:397-398.
11. Andaleeb SS, Tallman RF. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study. Health Mark Q. 1996;13:79-89.
12. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med. 1983;308:1457-1463.
13. Soumerai SB, Avorn, J. Economic and policy analysis of university-based drug "detailing." Med Care. 1986;24:313-331.
14. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-483.
15. Maguire P. Samples: cost-driver or safety net? ACP Observer (online); 2001. Available at: http://www.acponline.org/journals/news/jan01/drugsamples. htm. Accessed July 25, 2006.
16. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118:881-884.
17. Hall KB, Tett SE, Nissen LM. Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Med Care. Apr 44:383-387, 2006.
18. Shaughnessy AF, Bucci KK. Drug samples and family practice residents. Ann Pharmacother. 1997;31:1296-1300.
19. Brewer D. The effect of drug sampling policies on residents' prescribing. Fam Med. 1998;30:482-486.
20. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J. 1995;153:553-559.
21. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:1593-1596.
22. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002;34:729-731.
23. Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academies Press; 2007.
24. Johnson K. Drug samples to doctors. New York Times. February 9, 2006:A26.
25. Stevens D, Sharma K, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma. 2003;40:789-793.
26. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9:305-312.
27. Cohen SB, DiGaetano R, Goksel H. Estimation procedures in the 1996 Medical Expenditure Panel Survey Household Component. Rockville, Md: Agency for Health Care Policy and Research; 1999. Available at: http://207.188.212.220/ mepsweb/data_files/publications/mr5/mr5.shtml. Accessed September 12, 2006.
28. Medical Expenditure Panel Survey. HC-077A: 2003 Prescribed Medicines. Rockville, MD: Agency for Healthcare Research and Quality; 2005. Available at: http://www.meps.ahrq.gov/mepsweb/survey_comp/hc_survey/2003/PM-p7r5.pdf. Accessed September 8, 2006.
29. Johnson D. Free (or Almost Free) Prescription Medications: Where and How to Get Them. San Francisco, Calif: Robert D. Reed Publishers; 2002.